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Pulmonary infections with Burkholderia cepacia complex organisms contribute significantly to morbidity and mortality in patients with
cystic fibrosis (CF), partially due to the intense inflammatory response of the host to the presence of bacteria and their byproducts. In the
present study we show that Burkholderia genomes contain a large number of immunostimulatory CpG motifs. This is mainly because of their
large genome size. This suggests that DNA from Burkholderia sp. has the potential to cause significant inflammatory response. Whether this
contributes significantly to the airway inflammation often observed in infected CF patients remains to be determined.
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In persons with cystic fibrosis (CF), pulmonary disease is
the major cause of morbidity and mortality; mutations in the
cftr gene result in an altered airway surface liquid (ASL)
which in some way predisposes the lungs to bacterial
infections [1]. Organisms typically associated with the
respiratory tract of CF patients are Staphylococcus aureus,
Haemophilus influenzae, Pseudomonas aeruginosa and
Burkholderia cepacia complex bacteria [2]. Due to the high
viscosity of respiratory secretions and the altered ASL,
normal host defense mechanisms are impaired and despite
the intense inflammatory response, the host does not have
the ability to clear the infection [3]. The continuous
presence of bacteria and their byproducts in the lungs of
CF patients leads to a vicious cycle in which the host
immune response leads to more tissue damage, leading to
more infection and further inflammation [4]. There are
strong indications that the inflammatory response to P.
aeruginosa infection is induced by lipopysaccharide (LPS),1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2005.03.001
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studies have shown that LPS from B. cepacia complex
bacteria can activate neutrophils [8] and stimulate tumor
necrosis factor a production [9,10]. There are also
indications that during infections with Burkholderia pseu-
domallei and Burkholderia mallei (the causative agents of
melioidosis and glanders, respectively) an intense inflam-
matory response is mounted (see for example Refs. [11,12]).
It has been known for over 20 years that bacterial DNA
can activate the human immune system [13–15]. Several
studies in the early 1990s showed that the immunostimu-
latory properties of bacterial DNA could be attributed to the
presence of unmethylated CpG dinucleotides [16–18].
Bacterial DNA can induce B-cells to proliferate and secrete
immunoglobulines [19], can induce the production of
immunomodulatory cytokines [20], can activate the acute
phase response [21] and can activate specific subsets of
dendritic cells [22]. It is thought that the response to CpG
motifs is mediated by the Toll-like receptor 9 (TLR9) [23–
25] and differences in human and murine TLR9 specificity
might explain why the immune system of both organisms is
stimulated by different CpG-containing motifs [25–27].
Several studies have indicated that TLR9 mediates the
immune response in a concentration-dependent way, i.e.4 (2005) 193 – 196ed by Elsevier B.V. All rights reserved.
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greater stimulatory capacity [28,29]. In addition, it has been
suggested that the immunomodulatory effects of DNA may
augment the inflammatory response to endotoxin, indicating
that the presence of bacterial DNA might increase the
sensitivity to toxic effects of LPS. In contrast to bacterial
DNA, vertebrate DNA shows a significant CpG suppression
[30,31] and it has been postulated that the vertebrate
immune system has evolved to recognise unmethylated
CpG motifs and can respond to them with a rapid and
coordinated cytokine response, leading to induction of
humoral and cell-mediated immunity.
In the present study we compared the occurrence of
CpG-containing motifs in the Burkholderia cenocepacia
strain J2315 genome with the occurrences in other bacterial
genomes, including those of other CF pathogens and other
Burkholderia species.2. Materials and methods
Complete genome sequences used in the present study
are shown in Table 1. We included all completely
sequenced Burkholderia genomes, as well as large contigs
of other Burkholderia genomes. For comparison we also
included (i) genome sequences of other CF pathogens and
(ii) genome sequences of other organisms with a com-
parable GC content and/or genome size. To determine the
dinucleotide relative abundance and absolute number and
frequencies of CpG-containing motifs of different lengths,Table 1
GC content, CpG dinucleotide relative abundance and absolute number and frequ
Species and strain designation Genome
size (bp)
GC content
(mol%)
Bordetella pertussis TohamaI 4,086,189 67.7
Bradyrhizobium japonicum USDA110 9,105,828 64.1
Burkholderia cenocepacia J2315* 7,963,121 67.0
Burkholderia pseudomallei K96243 7,247,547 68.1
Burkholderia mallei ATCC 23344 5,835,527 68.3
Burkholderia cepacia complex R-18194 contig 88* 1,344,092 66.7
Extrapolated for entire genome T8600,000 –
Burkholderia vietnamiensis R-1808 contig 437* 411,398 65.7
Extrapolated for entire genome T8200,000 –
Burkholderia xenovorans LB400T contig 715* 1,927,480 62.7
Extrapolated for entire genome T9700,000 –
B. cepacia complex SAR-1 scaffold 2204886 2,098,317 66.7
Caulobacter crescentus CB15 4,016,947 67.2
Chromobacterium violaceum ATCC 12472 4,751,080 64.8
Desulfovibrio vulgaris Hildenborough 3,570,858 63.1
Escherichia coli K12 4,639,221 51.8
Haemophilus influenzae Rd 1,830,138 38.1
Mycobacterium tuberculosis H37Rv 4,411,532 65.6
Pseudomonas aeruginosa PAO1 6,264,403 66.6
Ralstonia solanacearum GMI1000 5,810,922 67.0
Staphylococcus aureus Mu50 2,878,040 32.9
Xanthomonas campestris ATCC 33913 5,076,188 65.1
All sequences were obtained from GenBank except *obtained from http://www.sa
psf.org/microbial/ (B. cepacia complex R-18194, B. vietnamiensis and B. xenovosequences were first concatenated with their inverted
complementary sequence using the EMBOSS package
(http://www.hgmp.mrc.ac.uk/software/EMBOSS). Dinu-
cleotide relative abundances q*XY were calculated using
the equation q*XY= fXY / fXfY where fXY denotes the
frequency of dinucleotide XY and fX and fY denote the
frequencies of X and Y, respectively [32]. Statistical theory
and data from previous studies [31,32] indicate that the
normal range of q*XY is between 0.78 and 1.23. Absolute
number and frequencies of the CpG-containing motifs 5V-
GTCGTT-3V and 5V-GACGTT-3V(considered to be the most
stimulatory for human and murine cells, respectively
[24,27]) were determined using compseq (EMBOSS). For
strains R-18194, R-1808 and LB400T, we extrapolated the
absolute number of CpG containing motifs based on the
numbers observed in the contigs listed in Table 1 and the
estimated total genome size. Statistical analyses were
performed using the SPSS 11.0.1 software package (SPSS
Inc., Chicago, IL).3. Results and discussion
GC content, CpG dinucleotide relative abundance and
absolute number and frequencies of CpG-containing motifs
are shown in Table 1. The q*CG values of all Burkholderia
genomes were significantly higher than those of the other
genomes (P <0.001). The total number of CpG motifs
ranged from 145,046 (H. influenzae) to 2,819,378 (B.
cepacia complex R-18194). The lowest density of CpGencies of CpG-containing motifs
q*CG CpG 5V-GTCGTT-3V 5V-GACGTT-3V
No. Freq. (%) No. Freq. (%) No. Freq. (%)
1.1505 1,078,033 13.19 1674 0.02048 1145 0.01401
1.2841 2,399,027 13.17 4804 0.02638 4992 0.02741
1.4949 2,689,262 16.71 5573 0.03462 4768 0.02962
1.5502 2,602,216 17.95 4189 0.02890 4381 0.03022
1.5521 2,123,594 18.19 3370 0.02887 3441 0.02948
1.4875 440,640 16.39 974 0.03623 816 0.03036
– 2,819,378 – 6232 – 5221 –
1.4579 129,366 15.72 280 0.03403 260 0.03403
– 2,578,528 – 5581 – 5182 –
1.3778 522,738 13.56 1218 0.03160 1029 0.02669
– 2,630,667 – 6130 – 5178 –
1.4761 687,966 16.39 1507 0.03591 1249 0.02976
1.1636 1,055,828 13.14 1990 0.02477 1735 0.02441
1.1151 1,113,449 11.72 1221 0.01285 2076 0.02185
1.0706 762,107 10.67 2157 0.03020 1788 0.02504
1.1591 6,932,73 7.47 2314 0.02494 2970 0.03201
1.0897 145,046 3.96 677 0.01851 532 0.01453
1.1832 1,123,596 12.74 2794 0.03167 2669 0.03025
1.1001 1,526,246 12.18 3106 0.02479 2258 0.01802
1.1972 1,560,296 13.43 2852 0.02454 2239 0.01927
0.9425 146,618 2.55 1192 0.02071 1155 0.02007
1.1323 1,216,768 11.99 2453 0.02416 1551 0.01528
nger.ac.uk/Projects/B_cenocepacia/ (B. cenocepacia) and http://genome.jgi-
rans).
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Fig. 1. Relation between genome size and absolute number and frequency
of (a) CpG motifs, (b) 5V-GTCGTT-3Vmotifs and (c) 5V-GACGTT-3Vmotifs. X-
axis: genome size (in base pairs). Left Y-axis: absolute number of motifs
(solid diamonds). Right Y-axis: frequency (%) of motifs (open squares). The
linear relation between genome size and absolute number of motifs are also
shown.
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this density was highest in B. mallei ATCC 23344
(18.19%). The motif GTCGTT was most abundant in B.
cepacia complex R-18194 (6232), while this motif was
only encountered 677 times in the H. influenzae genome.
The same trend was observed for the GACGTT motif,
which was most abundant in B. cepacia complex R-18194
(5221), while this motif was only encountered 532 times in
the H. influenzae genome. The density of the GTCGTT
motif was also highest in B. cepacia complex R-18194
(0.03623%), while the C. violaceum genome had the
lowest density for this motif (0.01285%). The highest
GACGTT motif density was found in B. vietnamiensis
(0.03403%), while the lowest density was found in the B.
pertussis genome (0.01401%). Not unexpectedly, there isan almost perfect linear correlation between genome size
and number of CpG motifs, GTCGTT motifs and
GACGTT motifs (r2=0.925, r2=0.932 and r2=0.919,
respectively) (P <0.01 for all correlations) (Fig. 1).
However, there is no correlation between genome size
and motif density (Fig. 1). There is also a significant (but
non-linear) relationship between GC content and the
absolute number of the various CpG motifs (data not
shown), as genomes with a higher GC content tend to have
more of these repeats. However, when controlling for the
effect of genome size (as larger genomes also tend to be
more GC-rich), this correlation is not significant. When we
compared the absolute number and frequency of CpG
motifs, we found that the absolute number of CpG motifs
is significantly higher in Burkholderia genomes than in
non-Burkholderia genomes (P <0.001). The absolute
number of GTCGTT and GACGTT motifs is also
significantly higher in Burkholderia genomes than in
non-Burkholderia genomes (P <0.01 for both motifs). In
contrast to the absolute numbers, the differences in
frequency are not statistically significant (data not shown).
Data from the present study show that Burkholderia
genomes contain a large number of immunostimulatory
CpG motifs and our statistical analyses indicate that this is
mainly due to their large size. This suggests that DNA from
Burkholderia sp. has the potential to cause significant
inflammatory response. Whether this contributes signifi-
cantly to the airway inflammation often observed in infected
CF patients (either directly or by increasing the sensitivity to
toxic effects of LPS and/or other bacterial products) remains
to be determined.Acknowledgements
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